SlideShare a Scribd company logo
1 of 10
REGISTRATION
REQUIRMENTS FOR CIS
COUNTRIES
SUBMITTED BY,
JAYA PRAKASH V,
218311.
UZBEKISTAN
• Uzbekistan: The Ministry of Health of the Republic of
Uzbekistan
I. General Documentation
• Administrative data
• Brief description of the medicinal product (SmPC), labeling
and instructions for use
• Detailed description of pharmacological surveillance and risk
management system
• Reports of independent experts on chemical, pharmaceutical
and biological documentation, pharmaco-toxicological
documentation
II. Chemical, pharmaceutical and biological documentation
• Composition
• Method of manufacturing (scheme of technological process,
draft of technological regulations)
• Methods for quality control of final product
• Stability data
• Information on dissolution profile
• Data on bioavailability, bioequivalence
III. Pharmacological and toxicological documentation
• Toxicity with single administration and administration of
repeated doses
• Data on teratogenicity, gonadotoxicity and embryotoxicity
• Data on carcinogenicity
• Additional safety information
IV. Clinical documentation
• Results of clinical trials.
• Additional information confirming effectiveness and safety,
quality, clinical effectiveness and safety.
GEORGIA
• Georgia: Ministry of Labor, Health and Social Affairs of
Georgia
• Registration requirements:
• Administrative documents
• legalized Power of Attorney from the applicant to the
representative
• legalized copy of instruction for medical use approved in
importing country together with its certified translation to
Georgian
• legalized copy of registration certificate issued by the
competent authority of importing country, where medicinal
product is registered
• legalized copy of certificate of a pharmaceutical product (CPP)
or Free Sale Certificate
• proposed mockups in Georgian and/or Russian and/or English
• specification(s) and methods of control of medicinal product
• Samples of medicinal product and standard samples
KYRGYZSTAN
• KYRGYZSTAN: ministry of health of the kyrgyz republic
• Registration requirements:
• Application for state registration
• Power of Attorney
• GMP compliance certificate
• Duly certified copy of license for production of medicines
issued by the authorized body
• Name of the medicinal product
• Description of appearance of the medicinal product for
medical use
• Physical and chemical properties
• Pharmacodynamics and pharmacokinetics
• Overdose symptoms ,relief measures in case of overdose
• Interaction with other medicinal products
• Information on possible effect of the medicinal product on the
ability to drive and operate machinery
• Shelf life and indication not to use the medicinal product after
its expiry
COMPARISON STUDY
Requirements UZBEKISTAN GEORGIA KYRGYZSTA
N
Site
registration
yes Yes yes
Stability Zone Zone I Zone I Zone I
Dossier Format Country specific CTD CTD
Language English & uzbic English &
russian
English &
kyrgyzic
THANK YOU

More Related Content

What's hot

EU Variations & Renewals
EU Variations & RenewalsEU Variations & Renewals
EU Variations & Renewals
Sachin Chede
 

What's hot (20)

Ghtf study group 4
Ghtf study group 4Ghtf study group 4
Ghtf study group 4
 
EU Variations & Renewals
EU Variations & RenewalsEU Variations & Renewals
EU Variations & Renewals
 
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
 
labelling of drugs and cosmetics in European Union
labelling of drugs and cosmetics in European Unionlabelling of drugs and cosmetics in European Union
labelling of drugs and cosmetics in European Union
 
Anvisa gudelines
Anvisa gudelinesAnvisa gudelines
Anvisa gudelines
 
Electronic submission PPT
Electronic submission PPTElectronic submission PPT
Electronic submission PPT
 
EU REGULATORY SUBMISSIONS
EU REGULATORY SUBMISSIONSEU REGULATORY SUBMISSIONS
EU REGULATORY SUBMISSIONS
 
regulatory approval process of drug, cosmetic and herbals in canada
regulatory approval process of drug, cosmetic and herbals  in canada regulatory approval process of drug, cosmetic and herbals  in canada
regulatory approval process of drug, cosmetic and herbals in canada
 
Abriviated new drug application 505(j) filling
Abriviated new drug application 505(j) fillingAbriviated new drug application 505(j) filling
Abriviated new drug application 505(j) filling
 
Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)
 
Dossier preparation and submission
Dossier preparation and submissionDossier preparation and submission
Dossier preparation and submission
 
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
 
ANDA Submission.pptx
ANDA Submission.pptxANDA Submission.pptx
ANDA Submission.pptx
 
Dossier Preparation/ CTD (Common Technical Document)
Dossier Preparation/ CTD (Common Technical Document)Dossier Preparation/ CTD (Common Technical Document)
Dossier Preparation/ CTD (Common Technical Document)
 
Quality, Safety and Legislation of Herbal Products in India
Quality, Safety and Legislation of Herbal Products in IndiaQuality, Safety and Legislation of Herbal Products in India
Quality, Safety and Legislation of Herbal Products in India
 
Dossier format and filing.pptx
Dossier format and filing.pptxDossier format and filing.pptx
Dossier format and filing.pptx
 
US FDA post approval changes
US FDA post approval changesUS FDA post approval changes
US FDA post approval changes
 
Marketing Authorization Procedure in European Union
Marketing Authorization Procedure in European UnionMarketing Authorization Procedure in European Union
Marketing Authorization Procedure in European Union
 
GHTF
GHTFGHTF
GHTF
 
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
 

Similar to Registration requirments for cis countries

Fda Social Media Guidance Agenda 2011
Fda Social Media Guidance Agenda 2011Fda Social Media Guidance Agenda 2011
Fda Social Media Guidance Agenda 2011
biopharmaguru
 
MEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPANMEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPAN
DeveshDRA
 

Similar to Registration requirments for cis countries (20)

5. Dr. Yuri Gamazin - Ministry of Health (Ukraine)
5. Dr. Yuri Gamazin - Ministry of Health (Ukraine)5. Dr. Yuri Gamazin - Ministry of Health (Ukraine)
5. Dr. Yuri Gamazin - Ministry of Health (Ukraine)
 
29. Prof. Sergey Tulyandin - Russian Scientific Oncology N.N. Blokhin Center
29. Prof. Sergey Tulyandin - Russian Scientific Oncology N.N. Blokhin Center29. Prof. Sergey Tulyandin - Russian Scientific Oncology N.N. Blokhin Center
29. Prof. Sergey Tulyandin - Russian Scientific Oncology N.N. Blokhin Center
 
33. Topical issues of monitoring of safety of medicines. Focus on biosimilars
33. Topical issues of monitoring of safety of medicines. Focus on biosimilars33. Topical issues of monitoring of safety of medicines. Focus on biosimilars
33. Topical issues of monitoring of safety of medicines. Focus on biosimilars
 
The regulation of complementary medicines
The regulation of complementary medicinesThe regulation of complementary medicines
The regulation of complementary medicines
 
4. Prof. Shinar Baidullaeva - National Center for Medicines, Medical Devices ...
4. Prof. Shinar Baidullaeva - National Center for Medicines, Medical Devices ...4. Prof. Shinar Baidullaeva - National Center for Medicines, Medical Devices ...
4. Prof. Shinar Baidullaeva - National Center for Medicines, Medical Devices ...
 
radc.pptx
radc.pptxradc.pptx
radc.pptx
 
121725101005-S1.pptx
121725101005-S1.pptx121725101005-S1.pptx
121725101005-S1.pptx
 
Regulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendmentsRegulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendments
 
Fda Social Media Guidance Agenda 2011
Fda Social Media Guidance Agenda 2011Fda Social Media Guidance Agenda 2011
Fda Social Media Guidance Agenda 2011
 
International drug regulatory affairs
International drug regulatory affairsInternational drug regulatory affairs
International drug regulatory affairs
 
MEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPANMEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPAN
 
Oncology Drugs: The journey From Manufacturer To The End User
Oncology Drugs: The journey From Manufacturer To The End UserOncology Drugs: The journey From Manufacturer To The End User
Oncology Drugs: The journey From Manufacturer To The End User
 
4.2 TT-Approved regulatory bodies and agencies.pdf
4.2 TT-Approved regulatory bodies and agencies.pdf4.2 TT-Approved regulatory bodies and agencies.pdf
4.2 TT-Approved regulatory bodies and agencies.pdf
 
Presentation: Medicinal Cannabis - what's happening?
Presentation: Medicinal Cannabis - what's happening?Presentation: Medicinal Cannabis - what's happening?
Presentation: Medicinal Cannabis - what's happening?
 
Pharmaceutical Regulations Outline
Pharmaceutical Regulations Outline Pharmaceutical Regulations Outline
Pharmaceutical Regulations Outline
 
REGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptxREGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptx
 
Market authorisation checklist for brics countries
Market authorisation checklist for brics countriesMarket authorisation checklist for brics countries
Market authorisation checklist for brics countries
 
Drug Regulatory Systems in India
Drug Regulatory Systems in IndiaDrug Regulatory Systems in India
Drug Regulatory Systems in India
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory Affairs
 
Drug regulation
Drug regulationDrug regulation
Drug regulation
 

More from JAYA PRAKASH VELUCHURI

More from JAYA PRAKASH VELUCHURI (17)

Tangential Flow Filtration - PPT.pptx
Tangential Flow Filtration - PPT.pptxTangential Flow Filtration - PPT.pptx
Tangential Flow Filtration - PPT.pptx
 
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptxBasics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
 
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSUREHUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
 
FIXED DOSE COMBINATIONS BANNED IN INDIA
FIXED DOSE COMBINATIONS BANNED IN INDIAFIXED DOSE COMBINATIONS BANNED IN INDIA
FIXED DOSE COMBINATIONS BANNED IN INDIA
 
AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA
AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA
AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA
 
HOMEOPATHY IN INDIA AND US OVERVIEW
HOMEOPATHY IN INDIA AND US OVERVIEWHOMEOPATHY IN INDIA AND US OVERVIEW
HOMEOPATHY IN INDIA AND US OVERVIEW
 
FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...
FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...
FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...
 
IMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONS
IMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONSIMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONS
IMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONS
 
CASE STUDY ON CHANGE CONTROL
CASE STUDY ON CHANGE CONTROLCASE STUDY ON CHANGE CONTROL
CASE STUDY ON CHANGE CONTROL
 
Documentation of raw material analysis for croscarmellose sodium
Documentation of raw material analysis for croscarmellose sodiumDocumentation of raw material analysis for croscarmellose sodium
Documentation of raw material analysis for croscarmellose sodium
 
Response to a warning letter
Response to a warning letterResponse to a warning letter
Response to a warning letter
 
Ge health care and mri
Ge health care and mriGe health care and mri
Ge health care and mri
 
Regulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inRegulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics in
 
ICH AND ICH GUIDELINES
ICH AND ICH GUIDELINESICH AND ICH GUIDELINES
ICH AND ICH GUIDELINES
 
Mutual recognition
Mutual recognitionMutual recognition
Mutual recognition
 
THIN LAYER CHROMATOGRAPHY
THIN LAYER CHROMATOGRAPHYTHIN LAYER CHROMATOGRAPHY
THIN LAYER CHROMATOGRAPHY
 
Gamp 5 overview by jaya prakash ra
Gamp 5 overview by jaya prakash raGamp 5 overview by jaya prakash ra
Gamp 5 overview by jaya prakash ra
 

Recently uploaded

Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.
Silpa
 
Module for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learningModule for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learning
levieagacer
 
CYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptxCYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptx
Silpa
 
The Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptxThe Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptx
seri bangash
 
Digital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptxDigital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptx
MohamedFarag457087
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
NazaninKarimi6
 
Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Silpa
 
LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.
Silpa
 
Human genetics..........................pptx
Human genetics..........................pptxHuman genetics..........................pptx
Human genetics..........................pptx
Silpa
 
Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.
Silpa
 

Recently uploaded (20)

Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.
 
Module for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learningModule for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learning
 
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIACURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
 
CYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptxCYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptx
 
Genome sequencing,shotgun sequencing.pptx
Genome sequencing,shotgun sequencing.pptxGenome sequencing,shotgun sequencing.pptx
Genome sequencing,shotgun sequencing.pptx
 
Atp synthase , Atp synthase complex 1 to 4.
Atp synthase , Atp synthase complex 1 to 4.Atp synthase , Atp synthase complex 1 to 4.
Atp synthase , Atp synthase complex 1 to 4.
 
FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and SpectrometryFAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
 
The Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptxThe Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptx
 
Digital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptxDigital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptx
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
 
Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.
 
Zoology 5th semester notes( Sumit_yadav).pdf
Zoology 5th semester notes( Sumit_yadav).pdfZoology 5th semester notes( Sumit_yadav).pdf
Zoology 5th semester notes( Sumit_yadav).pdf
 
LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.
 
Human genetics..........................pptx
Human genetics..........................pptxHuman genetics..........................pptx
Human genetics..........................pptx
 
Factory Acceptance Test( FAT).pptx .
Factory Acceptance Test( FAT).pptx       .Factory Acceptance Test( FAT).pptx       .
Factory Acceptance Test( FAT).pptx .
 
Cyanide resistant respiration pathway.pptx
Cyanide resistant respiration pathway.pptxCyanide resistant respiration pathway.pptx
Cyanide resistant respiration pathway.pptx
 
Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.
 
Use of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxUse of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptx
 
PATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICE
PATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICEPATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICE
PATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICE
 
Selaginella: features, morphology ,anatomy and reproduction.
Selaginella: features, morphology ,anatomy and reproduction.Selaginella: features, morphology ,anatomy and reproduction.
Selaginella: features, morphology ,anatomy and reproduction.
 

Registration requirments for cis countries

  • 2. UZBEKISTAN • Uzbekistan: The Ministry of Health of the Republic of Uzbekistan I. General Documentation • Administrative data • Brief description of the medicinal product (SmPC), labeling and instructions for use • Detailed description of pharmacological surveillance and risk management system • Reports of independent experts on chemical, pharmaceutical and biological documentation, pharmaco-toxicological documentation
  • 3. II. Chemical, pharmaceutical and biological documentation • Composition • Method of manufacturing (scheme of technological process, draft of technological regulations) • Methods for quality control of final product • Stability data • Information on dissolution profile • Data on bioavailability, bioequivalence
  • 4. III. Pharmacological and toxicological documentation • Toxicity with single administration and administration of repeated doses • Data on teratogenicity, gonadotoxicity and embryotoxicity • Data on carcinogenicity • Additional safety information IV. Clinical documentation • Results of clinical trials. • Additional information confirming effectiveness and safety, quality, clinical effectiveness and safety.
  • 5. GEORGIA • Georgia: Ministry of Labor, Health and Social Affairs of Georgia • Registration requirements: • Administrative documents • legalized Power of Attorney from the applicant to the representative • legalized copy of instruction for medical use approved in importing country together with its certified translation to Georgian
  • 6. • legalized copy of registration certificate issued by the competent authority of importing country, where medicinal product is registered • legalized copy of certificate of a pharmaceutical product (CPP) or Free Sale Certificate • proposed mockups in Georgian and/or Russian and/or English • specification(s) and methods of control of medicinal product • Samples of medicinal product and standard samples
  • 7. KYRGYZSTAN • KYRGYZSTAN: ministry of health of the kyrgyz republic • Registration requirements: • Application for state registration • Power of Attorney • GMP compliance certificate • Duly certified copy of license for production of medicines issued by the authorized body • Name of the medicinal product • Description of appearance of the medicinal product for medical use
  • 8. • Physical and chemical properties • Pharmacodynamics and pharmacokinetics • Overdose symptoms ,relief measures in case of overdose • Interaction with other medicinal products • Information on possible effect of the medicinal product on the ability to drive and operate machinery • Shelf life and indication not to use the medicinal product after its expiry
  • 9. COMPARISON STUDY Requirements UZBEKISTAN GEORGIA KYRGYZSTA N Site registration yes Yes yes Stability Zone Zone I Zone I Zone I Dossier Format Country specific CTD CTD Language English & uzbic English & russian English & kyrgyzic